News
There’s reason to remain bullish about Merck’s growth prospects in the long run. And at a discounted price, the stock could ...
However, beneath this success lies a growing concern: the sustainability of this growth trajectory, particularly as ...
Merck has received approval from the Food and Drug Administration to expand use of its blockbuster drug, Keytruda, to treat ...
Merck's oral cholesterol pill succeeded in two late-stage studies, marking a win for the drugmaker as it focuses on the ...
Merck's Keytruda receives FDA approval for head and neck cancer after showing improved event-free survival in Phase 3 KEYNOTE ...
1d
News-Medical.Net on MSNBenchling and Merck collaborate on vaccine bioanalysisBenchling announced a new collaboration with Merck, known as MSD outside of the United States and Canada, to implement a ...
Merck & Co. said it won US approval for a shot that protects against RSV, the most common cause of hospitalization among ...
Merck & Co.’s ambition to get the first oral PCSK9 inhibitor to market came one step closer this morning as the pharma ...
Citizens Financial Group (CFG) will be expanding its share buyback program to $1.5 billion. Pharmaceutical giant Merck (MRK) ...
Merck is establishing a program of clinical trials for V181, including conducting trials globally, in places where dengue is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results